Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Change in Receivables (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Change in Receivables for 3 consecutive years, with -$31.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 308.73% year-over-year to -$31.4 million, compared with a TTM value of $131.3 million through Dec 2025, down 26.67%, and an annual FY2025 reading of $131.3 million, down 26.67% over the prior year.
  • Change in Receivables was -$31.4 million for Q4 2025 at BrightSpring Health Services, down from $49.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $115.6 million in Q1 2024 and bottomed at -$31.4 million in Q4 2025.
  • Average Change in Receivables over 3 years is $36.5 million, with a median of $41.6 million recorded in 2025.
  • Peak annual rise in Change in Receivables hit 1190.6% in 2025, while the deepest fall reached 308.73% in 2025.
  • Year by year, Change in Receivables stood at $10.3 million in 2023, then skyrocketed by 45.72% to $15.0 million in 2024, then plummeted by 308.73% to -$31.4 million in 2025.
  • Business Quant data shows Change in Receivables for BTSG at -$31.4 million in Q4 2025, $49.9 million in Q3 2025, and $33.3 million in Q2 2025.